Aug 06, 2021 / NTS GMT
Presentation
Aug 06, 2021 / NTS GMT
=====================
Corporate Participants
=====================
* Akihisa Nabeshima
Teijin Limited - Executive Officer, CFO & Representative Director
* Junji Kitahama
=====================
Akihisa Nabeshima - Teijin Limited - Executive Officer, CFO & Representative Director
Good evening. This is Akihisa Nabeshima, the CFO. Thank you for joining us today. I would like to go over the results of fiscal 2021 first quarter and the full year outlook for fiscal 2021.
Please turn to Page 1, where you can see the key points of this earnings report. First, the results for the first quarter. Thanks to the global economic recovery from the impact of the COVID-19 pandemic and the transfer of sales rights of diabetes treatments from Takeda Pharmaceutical Company, EBITDA increased 32% year-on-year at JPY 33.9 billion, representing a 26% progress of the full year forecast of JPY 130 billion. Operating income increased 37% year-on-year at JPY 17.3 billion, as shown in the right graph, representing 29% of the
Q1 2022 Teijin Ltd Earnings Presentation Transcript
Aug 06, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers